Management of adolescent confidentiality and sensitive services has always posed challenges to medical clinicians. State and federal laws, as well as institutional policies, may dictate what information can or cannot be shared by a clinician with a parent or guardian of an adolescent. Clinicians concerned about diagnosis disclosure via insurance notifications may limit their testing or prescription, refer sensitive services to more specialized reproductive health clinics, or appeal to non-insurance funders to cover sensitive testing and confidential prescriptions. All factors may be burdensome to patients, families, and/or clinicians.
top of page
Search
Recent Posts
See Allhttps://www.nytimes.com/2020/03/27/podcasts/the-daily/kids-coronavirus.html?rref=vanity What is a virus? What does COVID-19 do to your body? Why do we cough? How does the COVID-19 start? Can pets get
80
https://pediatrics.aappublications.org/content/early/2020/01/07/peds.2019-1324 Family Partnership articles reflect the joint perspective of patients, families, and the health care professionals taking
110
https://pediatrics.aappublications.org/content/early/2020/01/21/peds.2019-1725 BACKGROUND AND OBJECTIVES: Gonadotropin-releasing hormone analogues are commonly prescribed to suppress endogenous pubert
110
bottom of page